Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 1992-1996

  Antoniazzi, Franco ^a   Bertoldo, Francesco ^a   Lauriola, Silvana ^a   Sirpresi, Stefania ^a   Gasperi, Elisabetta ^a   Zamboni, Giorgio ^a   Tatò, Luciano ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CARBONATE; GLUCONOLACTATE CALCIUM; GONADORELIN AGONIST; TRIPTORELIN;

ARTICLE; BONE AGE; BONE DEMINERALIZATION; BONE DENSITY; BONE MASS; BONE MINERAL; CALCIUM INTAKE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SUPPLEMENTATION; TREATMENT OUTCOME;

EID: 0033305363     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.6.5791     Document Type: Article

References (43)

1. Peak bone mass
2. Skeletal age as a determinant of bone mass in preadolescent females
3. Role of growth hormone and sex steroids in achieving and maintaining normal bone mass
4. Reduction of bone density: An effect of gonadotropin releasing hormone analogue treatment in central precocious puberty
5. Bone mineral metabolism in girls with precocious puberty during gonadotropin releasing hormone agonist treatment
6. Pathophysiology and treatment of sexual precocity
7. Final height in girls with central precocious puberty. Comparison of two different Luteinizing Hormone-Releasing Hormone agonist treatments
8. Calcium supplementation and increases in bone mineral density in children
9. Calcium-enriched foods and bone mass growth in prepubertal girls: A randomized, double-blind, placebo-controlled trial
10. Laboratory monitoring of children with precocious puberty
11. Bone mineral density in children and adolescents: Relation to puberty, calcium intake, and physical activity
12. The two faces of growth: Benefits and risks to bone integrity
13. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects
14. Volumetric bone mineral density in normal subjects, aged 5-27 years
15. Heritable and life-style determinants of bone mineral density
16. Effects of heredity, age, weight, puberty, activity, and calcium intake on bone mineral density in children
17. Influence of body composition on bone mineral content in children and adolescents
18. Influences on skeletal mineralization in children and adolescents: Evidence for varying effects of sexual maturation and physical activity
19. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents
20. Influence of muscle strength on bone strength during childhood and adolescence
21. Supplementation trials with calcium citrate malate: Evidence in favor of increasing the calcium RDA during childhood and adolescence
22. The effect of calcium supplementation and Tanner stage on bone density, content and area in teenage women
23. A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males
24. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial
25. A 4-year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women
26. Changes in calcium kinetics associated with menarche
27. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
28. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: Impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood
29. Growth hormones and sex steroid interactions at puberty
30. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty
31. 3
32. Effects of two different regimens of recombinant human growth hormone therapy on bone mineral density of patients with growth hormone deficiency
33. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset
34. Spinal and femoral bone mass accumulation during normal adolescence: Comparison with female patients with sexual precocity and with hypogonadism
35. Bone mineral density during treatment of central precocious puberty
36. Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog
37. Bone mineralization and bone maturation in precocious puberty
38. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay
39. Biochemical effects of calcium supplementation in postmenopausal women: Influence of dietary calcium intake
40. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women
41. The effect of long-acting analog of luteinizing hormone releasing hormone on growth hormone secretory dynamics in children with precocious puberty
42. Calcium metabolism in girls: Current dietary intakes lead to low rates of calcium absorption and retention during puberty